Public Policy Resources

The American Cancer Society Cancer Action Network (ACS CAN) calls on Congress to support the Centers for Disease Control and Prevention’s (CDC) NationalProgram for Cancer Registries (NPCR). Accessible, high-quality and usable registry data is critical to protect health and save lives.

The CDC’s Division of Cancer Prevention and Control (DCPC) plays a crucial role in providing millions of screening exams, funding state cancer registries, providing technical assistance and funding to state cancer control programs and educating the public directly on how to reduce their risk of c

The Centers for Disease Control and Prevention’s (CDC) Colorectal Cancer Control Program (CRCCP) provides grant funding to 20 state health departments, eight universities, two tribal organizations, and five other organizations to help prevent colorectal cancer, the third most common cancer in men and women and the second leading cause of cancer death in the U.S. for men and women combined.

El cáncer de seno es el tipo de cáncer que se diagnostica con mayor frecuencia en mujeres en EE.UU. Aunque en lasúltimas décadas se han logrado avances sustanciales en la reducción de la mortalidad por esta enfermedad,persisten desigualdades, especialmente entre las mujeres de raza negra.

The American Cancer Society Cancer Action Network (ACS CAN) urges Congress to reauthorize the the National Breast and Cervical Cancer Early Detection Program (NBCCEDP) to provide the program greater flexibility to NBCCEDP grantees, enabling them to implement evidence-based lifesaving screening, diagnostic, and treatment services and continue the innovative work aimed to reduce breast and cervical cancer disparities by passing the Screening for Communities to Receive Early and Equitable Needed Services (SCREENS) forCancer Act (H.R. 2381/S. 1866). This is critical to overall efforts to ensure that everyone has a fair and just opportunity toprevent, detect, treat and survive cancer.

ACS CAN supports the Access to Breast Cancer Diagnosis Act to increase access to no cost breast cancer screening, including all diagnostic and supplemental tests.

Our latest survey finds that 31% of screening-age adults have been more than one year behind on recommended routine cancer screenings. Over half say out-of-pocket costs are a barrier to getting screened, while 47% report that getting insurance approvals for covered screenings is a barrier.

Breast cancer is the most common cancer diagnosed in women in the U.S. Although there has been substantial progress in reducing breast cancer mortality in the US over the past several decades, there are persistent disparities, especially among Black women. Additionally, breast cancer incidence is increasing, with the steepest trends among young women under 50. In 2025, an estimated 316,950 women in the U.S. will be diagnosed with invasive breast cancer with an additional 59,080 cases of ductal carcinoma in situ (DCIS) in women, and 42,680 will die from the disease. 

ACS CAN supports the Women and Lung Cancer Research and Preventive Services Act of 2025 to accelerate progress in reducing mortality from lung cancer.